Lifeboat Foundation

The hepatitis B virus (HBV), which spreads through blood and bodily fluids and invades liver cells, is thought to kill just under 1 million people every year around the world, mostly from cancer or scarring (cirrhosis) of the liver. HBV is less likely to be fatal than HIV, and many people who carry the virus don’t have symptoms. But because more than 250 million people live with chronic HBV infections, more than 7 times the number with HIV, its global death toll now rivals that of the more-feared virus.

Viral hepatitis is on the rise. Tackling hepatitis B in Africa is key to fighting back. Viral hepatitis is on the rise. Tackling hepatitis B in Africa is key to fighting back.

Optical fibers are then inserted through an area called the perineum, found between the testes and the anus, and directly into the prostate gland. Afterwards, the scientists turn on a red laser that is induced through the optical fibers. This process utilizes the photosensitivity of the WST11 drug and activates it. Upon activation, free radicals are released within the area, attacking and destroying the tumors. Unlike conventional treatments which might affect a general area of body cells, this treatment is localized. The nearby cells are left more or less unharmed.

Beating The Big ‘C’

The trial for this prostate cancer treatment has shown promising results. Endgadget reports that, from the 415 participating men, nearly half were rid of the malignant disease by the end of treatment. This is a huge improvement compared to conventional procedures, which only have an average success rate of about 14 percent. Of those that had cancer in remission, only six percent needed to have their affected prostate removed, which is again a stark contrast to the conventional procedures’ 30 percent.

Continue reading “Lasers Cure Nearly 50% of Patients With Prostate Cancer in New Study” »

Project for Awesome (P4A) 2018 is finally here, and you can help us to win much-needed funds at no cost to you by voting for the videos supporting our charity.

Every year, a number of charities are chosen through voting, and they each receive a sum of money based on what the fundraiser at P4A has raised. In the past, charities have received around $25,000 each, which is a considerable sum, especially for a small non-profit org such as LEAF.

Continue reading “Support the Drive to End Age-Related Diseases During Project for Awesome” »

‘Chemo brain’ affects many people who have undergone cancer treatment. What happens in the brain, and how can we reverse this effect?

Continue reading “Regenerage — SMX Radio — The Net of Regenerative Medicine — Bioquark” »

Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported.

The discovery could help prevent some cases of the disease by treating vitamin D deficiency during the earliest stages of life.

The study, led by Professor John McGrath from The University of Queensland (UQ) in Australia and Aarhus University in Denmark, found newborns with vitamin D deficiency had a 44 per cent increased risk of being diagnosed with schizophrenia as adults compared to those with normal vitamin D levels.

Continue reading “Link between neonatal vitamin D deficiency and schizophrenia confirmed” »

The question and answer interview of He Jianku conference presentation has the most interesting parts of this debate about human gene editing of embryos. The interview starts at about 1 hour and 28 minutes of the record. The formal presentation showed that the scientist He has taken appropriate scientific care to perform the work. He took care to make sure it was on target and was successful. He took care to make sure there were no unintended off-target side-effects.

* the parents (father HIV positive) made a choice to use the edited embryos versus unedited * the CRISPR vector used to make the change. Appears to be the kind that can be ordered for about $100. There have been adult people who have self-experimented with mail order gene editing kits * the conference interviewer asked about whether He Jianku was aware of a few other research papers. Some paper suggests that the gene CCR5 could cause increased susceptibility to flu and another suggests a tiny increase in cognitive effect.

Continue reading “Theoretically Possibility That Gene Edited Twins Received a Tiny Intelligence Enhancement” »

Imagine one drug that can target and kill malignant cells for some patients with many types of cancer. A new drug called Vitrakvi (larotrectinib), now approved by the U.S. Food and Drug Administration, shows promise of doing just that for both adults and children with a variety of sometimes rare cancers that share one specific genetic mutation.

The mutation, called a TRK fusion, occurs when one of three NTRK genes becomes mistakenly connected to an unrelated gene and ignites uncontrolled growth. By solely targeting this mutation, the drug is designed to turn off growth signaling with a minimum of other toxicities.

According to the drug manufacturer, Loxo Oncology, this specific mutation can occur in a small subset of various adult and pediatric solid tumors ranging from cancers of the appendix, bile ducts, breast, lung, pancreas and thyroid to melanoma, GIST and various sarcomas.

Continue reading “FDA Approves Drug That Targets Key Genetic Driver of Cancer” »

The promise of quantum computing brings with it some mind-blowing potential, but it also carries a new set of risks, scientists are warning.

Specifically, the enormous power of the tech could be used to crack the best cyber security we currently have in place.

A new report on the “progress and prospects” of quantum computing put together by the National Academies of Sciences, Engineering, and Medicine (NASEM) in the US says that work should start now on putting together algorithms to beat the bad guys.

Continue reading “We Need to Prepare For Quantum Attacks Now, Top US Scientists Warn” »